CYP2C19*3/*18 AND Citalopram response
- Germline classification:
- drug response (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000782526.10
Allele description [Variation Report for CYP2C19*3/*18]
NM_000769.1(CYP2C19):c.636G>A (p.Trp212Ter)
NM_000769.4(CYP2C19):c.986G>A (p.Arg329His)
Condition(s)
- Name:
- Citalopram response
- Synonyms:
- Celexa response
- Identifiers:
- MedGen: CN221263
Assertion and evidence details
Last Updated: Dec 7, 2024